Surgical Incision Closure Market Growth, Share And Forecasts 2014 To 2020

Surgical incision closure market is expected to register significant growth over the forecast period owing to increasing investment in research and development, reduced level of trauma along with reducing risks of infection, and increasing demand to shorten length of hospital stay. Appropriate incision closure during surgery is crucial to maintain integrity of tissues and regain normal functions. Primary objective during a surgery is to achieve hemostasis and to seal the incision both internally and externally. Any failure to seal the incisions perfectly leads to severe medical conditions such as infection and critical scarring. Introduction of technologically advanced incision closure products is additionally expected to propel growth of this market.

Surgical incision and closure market is segmented on three different bases such as type, application and products. On the basis of type market is divided into advanced wound care market and advanced wound closure market. Burns, ulcers and surgical wounds are the market types based on application. Sutures, tissue sealants and staplers are the three types on the basis of products. Sutures possess one of the highest market share and are expected to continue the dominance owing to the expansive product development efforts. For instance, recently developed barbed suture technology is designed to face challenging procedures such as endoscopic surgeries. Tissue sealants on the other hand is gaining market share steadily. Their demand is specially rising in case of cosmetic and minimally invasive surgeries. Surgical staplers continue to generate majority of sales. They have applications in many gynecologic, thoracic, and pediatric procedures but bariatric and emphysema market accounts for major share.

North America is expected to have the largest share due to higher consumer base of aesthetic surgeries, spinal fusion, and rising numbers of hip and knee replacement surgeries. Asia Pacific is expected to register a lucrative growth owing to improvement in healthcare infrastructure, rising spending in healthcare segment, new establishments of healthcare & diagnostic centers, and increased access to healthcare services.

Major players of the market are BTG plc, Cryolife, 3M healthcare, Ethicon, Covidien Plc., Smith and Nephew, Baxter International, Genzyme Biosurgery, Axya medical, Henkel Loctite Corporation and Tyco healthcare.

Request for toc of this report at:

http://www.grandviewresearch.com/industry-analysis/surgical-incision-closure-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Healthcare Analytics Market Revenue To Near $42.8 Billion By 2024:Grand View Research, Inc.

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

                                      Predictive Analytics market estimates and trends

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the study suggest:

• Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.

• The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.

• The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.

• On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.

• The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.

• The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.

• The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.

• North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.

• The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.

• Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

• For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

Grand View Research has segmented the global healthcare analytics market on the basis of products, end-use, and region:

Global Healthcare Analytics Market by Type, 2013 - 2024 (USD Million)

• Descriptive Analytics

• Predictive Analytics

• Prescriptive Analytics

Global Healthcare Analytics Market by Component, 2013 - 2024 (USD Million)

• Software

• Hardware

• Services

Global Healthcare Analytics Market, by Delivery Mode, 2013 - 2024 (USD Million)

• On-premise

• Web-based

• Cloud-based

Global Healthcare Analytics Market, by Application, 2013 - 2024 (USD Million)

• Clinical

• Financial

• Operational and Administrative

Global Healthcare Analytics Market, by End-use, 2013 - 2024 (USD Million)

• Healthcare Payers

• Healthcare Providers

• Others

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market/request

Laboratory filtration market is expected to reach USD 3.6 billion by 2024, according to a new report by Grand View Research, Inc.

The laboratory filtration market is expected to reach USD 3.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing number of target diseases such as water-borne diseases, immunodeficiency diseases, and cancer is anticipated to boost the market growth. The increasing use of filtration technologies such as microfiltration, nanofiltration, and ultrafiltration in water purification plants is expected to enhance growth in this sector.

                                  U.S. Laboratory Filtration Market by Product, 2013 - 2024 (USD Million)

Technological advancements in filtration products have resulted in an increase in the adoption rate of these products in clinical laboratories for research purposes. The products introduced provide benefits such high reliability, competency, and high throughput over the conventional methods. For instance, Merck Millipores millex syringe filters filter small-volume filtrates and these filters are ideally used for antibiotics and tissue culture additives.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market

Further Key Findings From the Study Suggest:

• The filtration media segment dominated this market in 2015, with a revenue share of over 40%.The large share is attributed to its cost-effective nature, higher efficiency, and reliability for industrial bioprocessing.

• Microfiltration assemblies dominated the assembly segment in 2015. Some of the benefits associated with microfilters such as easier availability, portability, and easier disposal make them the highly preferred technology.

• The microfiltration technology segment held the largest share in 2015, owing to the increasing application of microfiltration in industrial biotechnology and associated research.

• North America dominated the overall market with a revenue share of over 42% in 2015, owing to the presence of well-equipped laboratories for life science research, increasing investments in R&D, and the presence of government funding programs for laboratory filter membrane business owners.

• Asia Pacific is anticipated to be the fastest growing region with a CAGR of over 8.3%in the forecast period.Factors such as economic development, untapped market opportunities, new emerging market, and advancing healthcare system with the aid of supportive government initiatives are anticipated to assist in growth.

• The presence of major market players enhances the penetration of laboratory filtration product in the market. Some of the key players are Merck Millipore, Sigma-Aldrich, GE Healthcare, Thermo Fisher Scientific, Sartorius Group, 3M Company, Cantel Medical Corporation, Macherey-Nagel Gmbh& Co. Kg.

• The key players are entering into collaborations such as mergers and acquisitions with other key players to increase their market share. For instance, in November 2015, Merck Millipore acquired Sigma-Aldrich to enhance its life science segment, and this business segment based in the U.S. is named as MilliporeSigma.

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market/request

Patient Portal Market Growth, Share And Segment Forecasts to 2024

The global patient portal market is expected to reach USD 5.2 billion by 2024, according to a new report by Grand View Research, Inc. The demand for Electronic Health Record (EHR) with a patient portal is expected to exhibit an upsurge over the forecast period, owing to the increasing demand, favorable government funding policies, and the continual technological advancements offered by the key industrial players. 

In May 2016, CureMD signed a pledge of Voluntary National Interoperability. This pledge stated that action plans to develop and implement rapid flow in healthcare information between providers, patients, and other concerned authorities are to be implemented. 

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/patient-portal-market

Further Key Findings From the Report Suggest: 

• Integrated Patient portal was identified as the most lucrative segment in 2015. The rapid shift of providers from their previous methods to the EHRs, advancements in technology, and increasing demand were some of the reasons for its largest market share. 

• In June 2015, ICON (a global drug development and service provider) launched its online “Firecrest Patient Portal” It was specifically designed for a person to understand the entire treatment process before consulting the provider and view information regarding clinical trials. 

• Moreover, this provided services such as online appointment registration, laboratory tests and reports, and other necessary facilities. 

• Also, as per a report by the European commission, 11regions across the European Union (EU) had participated in the “Sustains project” since 2012, which was EU sponsored. This project was an initiative for joint learning, providing patients’ access to their health records and other online services. 

• North America dominated the market in 2015 as a result of the technological advancements and implementation of healthcare IT in the region. 

• In June 2014, Brattleboro Memorial Hospital launched “myHealthPortal.” It is expected to provide easy and early access to the selected portions of the health records. It is safe and secure, providing confidential communication between the providers and the patient. 

• Europe is expected to grow at a higher rate over the forecast period due to increasing demand of efficient healthcare delivery and advanced solutions. Increased government initiatives in the region and deployment of EHR-based portal solutions are considered responsible for its high growth rate. 

• In November 2015, an event was organized in the European Parliament by members of the European Parliament, Health Policy Partnership, Lung Cancer Europe, and European Cancer Patient’s Coalition. This event witnessed the launch of an Immuno-oncology Patient Portal that proved to be a unique solution for people suffering from cancer in Europe. 

• Developers are collaborating and expanding with the aim of combining the use of innovation and technology to improve efficiency and provide better services for the convenience of the providers. 

• In 2016, McKesson Corporation announced a partnership with Blue Cross Blue Shield of Arizona. This partnership will help deliver a broad range of services, thereby assisting the service providers. 

• In 2015, GE Healthcare announced the acquisition of Camden Group in order to provide their clients access to analytics that involves change management and activation resources, which support organizational and clinical changes. 

• Some key players in this market are GE Healthcare, Allscripts Healthcare Solutions, McKesson Corporation, and Cerner Corporation. 

Grand View Research has segmented the global patient portal market on the basis of type, deployment mode, end use, and regions: 

Patient Portal Type Outlook (Revenue, USD Million, 2013 – 2024)

• Standalone Patient Portal

• Integrated Patient Portal

Patient Portal Deployment Mode Outlook (Revenue, USD Million, 2013 – 2024)

• Web-Based Delivery

• Cloud-Based Delivery

Patient Portal End-Use Outlook (Revenue, USD Million, 2013 – 2024)

• Providers

• Players

• Pharmacies

• Others

To get full details at:

http://www.grandviewresearch.com/industry-analysis/patient-portal-market/request

Single Cell Analysis Market To Be Driven By Increasing Demand In healthcare scenario - Grand View Research

The global Single Cell analysis market is expected to reach USD 5.0 billion by 2024, according to a new report published by Grand View Research, Inc. The rising adoption of Single Cell analysis tools owing to the improving healthcare scenario is fueling the growth of the market.

The continuous efforts in the R&D sector of the healthcare industry are resulting in the wide applicability of the Single Cell analysis technologies in the different disease areas, as a widespread diagnostic tool to address the complex heterogeneity observed in cells. Introduction of stem cell therapies and non-invasive techniques for prenatal analysis are some of the examples of the applications of the Single Cell analysis techniques. On the contrary, the high-cost and long shelf-life of the instruments is challenging the growth of the market.

                      China Single Cell Analysis Market, by Instrument type, 2014 - 2024 (USD Million)

In addition, the increasing pool of individuals suffering from target diseases, such as cancer, and neurological disorders, rising per capita income, and the government initiatives to encourage the R&D in healthcare sectors are augmenting the demand for Single Cell analysis in the developing countries. The extensive demand for non-invasive techniques for prenatal diagnosis to prevent the immunological and genetic disorders in fetuses is fueling the demand for Single Cell tests in the market. The penetration of advanced therapeutic tools for the treatment of chronic diseases, such as cancer related to the malfunctions of the Single Cells is proving to be a boon for the global market. Moreover, the adoption of stem cell therapy for treatments related to bone marrow transplants, hair regeneration, and other health-related issues is widening the scope of the Single Cell analytical technologies globally.

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). North America accounted for the largest market share and was followed by Europe in 2015.Well-developed healthcare and R&D infrastructure and the availability of skilled labor are pushing the adoption of Single Cell analysis in these regions.

AsiaPacificis expected to show the fastest growth rate during the forecast period. Factors, such as the booming medical tourism, availability of advanced healthcare treatments, and the availability of skilled healthcare professionals at a lower cost are some of the factors anticipated to accelerate the adoption of Single Cell analysis in the Asia Pacific region. Moreover, the increasing government expenditure for clinical research activities and the improvement of healthcare infrastructure are boosting the growth of the market. As a result, the Asia Pacific market is anticipated to capture around 21% of the global share during the forecast period.

Players are implementing strategies, such as partnerships, collaborations, and mergers to expand their market share. The collaborative agreement between Illumina, Inc. and Bio-Rad Laboratories, Inc. is one such example of the strategic endeavors undertaken by the market players.

Further key findings from the study suggest:

• The consumables segment accounted for the largest market share and is expected to maintain its dominance owing to the repeat purchase of reagents, assay kits, beads, and microplates

• The instruments market segment is expected to show significant growth during the forecast period

• The applications segment of the market is further divided into cancer, neurology, immunology, prenatal diagnosis, and in-vitro fertilization. Increasing prevalence of the target diseases is propelling the growth of the market. 

• North America captured the largest market share of around 38% in 2015 and is estimated to maintain its dominance throughout the forecast period. Speedy adoption of analytical techniques and the rising R&D efforts in the field of diagnostics are the major factors contributing to the largest market share of North America in the global market. The AsiaPacific region is expected to show significant growth from 2016 to 2024 due mainly to the flourishing clinical research sector, medical tourism, and the high government healthcare expenditure in the region.

• The major market players in this market include but are not limited to Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.)

Download free sample request at:

http://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request

Post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022

Global post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of Adverse Drug Reactions (ADRs) coupled with incorporation of advanced ADR reporting tools is responsible for the overall growth of the post-marketing pharmacovigilance and medical information market. Increased drug consumption can be attributed to rising prevalence of chronic diseases such as tuberculosis that involve multiple drug regimes.

Post-marketing pharmacovigilance penetration and future growth opportunities, bytype of reporting

Rising government initiatives for improvement of pharmacovigilance services and maintenance of medical databases are also responsible for inducing overall growth of post-marketing pharmacovigilance and medical information market. For instance, in December 2015, the USAID Systems for Improved Access to Pharmaceuticals and Services (SIAPS) launched PViMS tool to improve drug safety monitoring in low and middle income countries by helping clinicians, researchers, and regulatory authorities to collect, analyze, and monitor ADRs.

View summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market

Further key findings from the study suggest:

• Spontaneous reporting dominated the post-marketing pharmacovigilance market in terms of revenue share as of 2014 and accounted for over 30.0% of market owing to wide usage in reporting of unknown and suspected ADRs. Preference of healthcare professionals and researchers towards this method is also responsible for the overall growth of this segment. 
• Cohort event monitoring is anticipated to be the fastest growing in post-marketing pharmacovigilance owing to application in all types of clinical events. Moreover, associated benefits such as early detection, high accuracy, and cost-efficiency are also anticipated to be the growth inducing factors. 
• Books dominated the overall product segment in terms of revenue share as of 2014 owing to the preference by clinicians and healthcare professionals as a primary source of information pertaining to adverse drug reactions. Online media is anticipated to be the fastest growing segment with a CAGR of over 13.0 % during the forecast period owing to rising inclination towards digitalized data. 
• Hospitals held the dominant share of end-use segment as a consequence of low costs associated with hospital based post-marketing pharmacovigilance surveillance. Research organizations segment is anticipated to show significant growth rate in coming years owing to streamlining of R&D in developing of new medicines and improving risk management through early prognosis of ADRs. 
• The key players of post-marketing pharmacovigilance and medical information market include Accenture Plc., Clinquest Group B.V., Cognizant Technology Solutions Corporation, Covance, Inc., iMEDGlobal Corporation, inVentiv Health Clinical, Parexel International Corporation, Pharmaceutical Product Development, Inc., PRA Health Sciences, Inc., Quintiles, F. Hoffmann-La Roche Ltd., Sanofi Aventis, Synowledge LLC, Wipro Ltd., ArisGlobal, Ergomed Plc. Rising strategic alliances and mergers &acquisitions are also anticipated to drive market growth. For instance, in January 2016, strategic collaboration of Parexel and Optum for reducingcosts related to post-approval studies and spreading awareness among the population base. 

To get free sample request:
http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market/request

Increasing demand for pneumonia market share and Forecasts 2015 to 2022

Global pneumonia market is expected to witness lucrative growth as the consequence of rising number of geriatric population and increasing prevalence of lung diseases, viral infections & heart diseases, among children thereby elevating the risk of developing pneumonia. Treatment advances facilitates benefits such as better efficacy & potency and lower incidence of potential side effects which are expected to drive the demand for the market over the forecast period. These advances include advent of new drugs namely trimethoprim-sulfamethoxazole and parental pentamidine isethionate. Moreover, better drug delivery & targeting techniques such as nebulization and aerosolization of drug facilitating relative ease of administration, high attainable drug levels and low side-effects are expected to drive the market growth potential further over the forecast period.

Access full research report at:

http://www.grandviewresearch.com/industry-analysis/pneumonia-market

The global pneumonia market is segmented on the basis of treatment drugs & vaccines market and mode of acquisition. On the basis of treatment drugs and vaccines, it is further segmented into antibiotics such as cephalosporins, penicillin, fluoroquinolones, tetracyclines, amoxicillin & vancomycin wheras vaccines include PCV13 & PPV23. On the basis of mode of acquisition, it is classified into hospital acquired pneumonia, community acquired pneumonia and ventilator acquired pneumonia. As of 2014, treatment drugs segment held the largest share of pneumonia market owing to the benefits such as better drug response, fast onset of action and higher efficacy & potency. On the basis of mode of acquisition, hospital acquired pneumonia held the largest market owing to factor such as increasing multidrug resistance in microorganisms in the hospital settings.

Geographically, pneumonia market is segmented into North America, Europe, Asia Pacific, Latin America and MEA. As of 2014, North America held the largest share in the pneumonia market owing to factors such as increasing multi drug resistance by microorganisms in viral infections among children and adults. Rising geriatric population and government initiatives are also responsible to drive the demand for pneumonia market in this region. For Instance, WHO and UNICEF Integrated Global Action Plan For Pneumonia and Diarrhoea (GAPPD) aims to accelerate pneumonia control with a combination of interventions to protect, prevent, and treat pneumonia in children and availability of advanced healthcare systems. Additionally, high awareness and disposable income are potential contributors to the growth of this market over the forecast period. Asia Pacific region is anticipated to be the fastest growing market due to prominent growth factors such as rising accessibility, increasing patient awareness, improving healthcare infrastructure and incremental disposable income.

The major players of the pneumonia market include Sanofi, AstraZeneca, GlaxoSmithCline, Eli Lilly, Merck & Co., Pfizer, Novartis and Baxter International Inc. These companies focus on crucial strategies such as development of innovative diagnostic systems, targeting developing regions and providing services aimed at better patient information & quality of life with better view for market penetration.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/pneumonia-market/request-toc